Tell me about dendritic cell therapy

Dendritic Cell Therapy for Cancer

Dendritic cell (DC) therapy is an emerging immunotherapy approach that trains your immune system to recognize and attack cancer cells. Let me explain how it works and what the current evidence shows.

How It Works

Dendritic cells are specialized immune cells that act like "messengers" — they capture information about cancer cells and teach your body's T cells (fighter immune cells) to recognize and destroy cancer. In dendritic cell therapy, doctors:

1. Collect dendritic cells from your blood
2. Load them with cancer-specific information (antigens or tumor material)
3. Expand them in the laboratory
4. Reinfuse them back into your body to trigger an immune response

Current Clinical Status

Important context: According to the NCCN (National Comprehensive Cancer Network) Guidelines, dendritic cell therapy remains largely investigational for most cancer types. However, there is one FDA-approved dendritic cell vaccine:

• Sipuleucel-T (Provenge®) — approved for metastatic castration-resistant prostate cancer. The American Cancer Society notes this treatment has shown modest survival benefits in clinical trials.

Where It's Being Studied

Dendritic cell therapy is being investigated in clinical trials for:

• Melanoma
• Ovarian cancer
• Colorectal cancer
• Other solid tumors and blood cancers

Next Steps

If you're interested in dendritic cell therapy:

• Ask your oncologist if clinical trials are appropriate for your specific cancer type
• Search ClinicalTrials.gov for active studies
• Discuss whether this fits your overall treatment plan

What cancer type are you dealing with? That would help me provide more specific information about what's available for your situation.